Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo
Clinical trial NCT00228462 · COMPLETED
Trial details
- NCT number
- NCT00228462
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.